BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Small Cell Lung Cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Diagnosis
106 results:

  • 1. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
    Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
    Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
    Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
    BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. miRNA-449c-5p regulates the JAK-STAT pathway in inhibiting cell proliferation and invasion in human breast cancer cells by targeting erbb2.
    Li L; Zhang Y; Yang K; Liu W; Zhou Z; Xu Y
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1974. PubMed ID: 38351535
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Deciphering the heterogeneity of neutrophil cells within circulation and the lung cancer microenvironment pre- and post-operation.
    Liu F; Liu X; Liu Y; Chen D; Liu X; Qin C; Song Y; Fang H; Wu D
    Cell Biol Toxicol; 2024 Feb; 40(1):11. PubMed ID: 38319415
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK lung Panel on the MassARRAY System in Metastatic Non-small cell lung cancer Patients.
    Leest PV; Janning M; Rifaela N; Azpurua MLA; Kropidlowski J; Loges S; Lozano N; Sartori A; Irwin D; Lamy PJ; Hiltermann TJN; Groen HJM; Pantel K; Kempen LCV; Wikman H; Schuuring E
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686200
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications.
    Seker-Cin H; Tay TKY; Kazdal D; Kluck K; Ball M; Neumann O; Winter H; Herth F; Heußel CP; Savai R; Schirmacher P; Thomas M; Budczies J; Allgäuer M; Christopoulos P; Stenzinger A; Volckmar AL
    Lung Cancer; 2023 Oct; 184():107317. PubMed ID: 37586177
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Advances in diagnosis and Treatment of her2-positive Non-small cell lung cancer].
    Ren C; Cao H; Zheng J; Sun W; Zhou J
    Zhongguo Fei Ai Za Zhi; 2023 Apr; 26(4):291-302. PubMed ID: 37183644
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Analyses of single extracellular vesicles from non-small lung cancer cells to reveal effects of epidermal growth factor receptor inhibitor treatments.
    Stridfeldt F; Cavallaro S; Hååg P; Lewensohn R; Linnros J; Viktorsson K; Dev A
    Talanta; 2023 Jul; 259():124553. PubMed ID: 37084607
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
    Isla D; Lozano MD; Paz-Ares L; Salas C; de Castro J; Conde E; Felip E; Gómez-Román J; Garrido P; Belén Enguita A
    Rev Esp Patol; 2023; 56(2):97-112. PubMed ID: 37061248
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Frequent Overexpression of HER3 in Brain Metastases from Breast and lung cancer.
    Tomasich E; Steindl A; Paiato C; Hatziioannou T; Kleinberger M; Berchtold L; Puhr R; Hainfellner JA; Müllauer L; Widhalm G; Eckert F; Bartsch R; Heller G; Preusser M; Berghoff AS
    Clin Cancer Res; 2023 Aug; 29(16):3225-3236. PubMed ID: 37036472
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Novel her2-Targeted Peptide for NIR-II Imaging of Tumor.
    Cao R; Li R; Shi H; Liu H; Cheng Z
    Mol Pharm; 2023 Feb; 20(2):1394-1403. PubMed ID: 36668683
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
    Isla D; Lozano MD; Paz-Ares L; Salas C; de Castro J; Conde E; Felip E; Gómez-Román J; Garrido P; Enguita AB
    Clin Transl Oncol; 2023 May; 25(5):1252-1267. PubMed ID: 36571695
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Chinese expert consensus on the diagnosis and treatment of her2-altered non-small cell lung cancer.
    Zhang S; Wang W; Xu C; Zhang Y; Cai X; Wang Q; Song Z; Li Z; Yu J; Zhong W; Wang Z; Liu J; Liu A; Li W; Zhan P; Liu H; Lv T; Miao L; Min L; Lin G; Huang L; Yuan J; Jiang Z; Pu X; Rao C; Lv D; Yu Z; Li X; Tang C; Zhou C; Zhang J; Guo H; Chu Q; Meng R; Liu X; Wu J; Zhou J; Zhu Z; Pan W; Dong X; Pang F; Wang K; Yao C; Lin G; Li S; Yang Z; Luo J; Jia H; Nie X; Wang L; Zhu Y; Hu X; Xie Y; Lin X; Cai J; Xia Y; Feng H; Wang L; Du Y; Yao W; Shi X; Niu X; Yuan D; Yao Y; Kang J; Zhang J; Zhang C; Gao W; Huang J; Zhang Y; Sun P; Wang H; Ye M; Wang D; Wang Z; Wan B; Lv D; Yu G; Shi L; Xia Y; Gao F; Zhang X; Xu T; Zhou W; Wang H; Liu Z; Yang N; Wu L; Wang Q; Wang G; Hong Z; Wang J; Fang M; Fang Y; Zhang Y; Song Y; Ma S; Fang W; Lu Y
    Thorac Cancer; 2023 Jan; 14(1):91-104. PubMed ID: 36444143
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Construction of IMMS Containing Multi-site Liposomes for Dynamic Monitoring of Blood CTC in Patients with Osimertinib-resistant Non-small-cell lung cancer and its Mechanism.
    Chen X; Luo L; Lu Y; Qiu Y; Liang J; Chen Y; Ning Y; Li B
    Anticancer Agents Med Chem; 2023; 23(6):676-686. PubMed ID: 36345240
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Non-small cell lung cancer with EGFR or her2 Exon 20 Insertion Mutations: diagnosis and Treatment Options.
    Brazel D; Kroening G; Nagasaka M
    BioDrugs; 2022 Nov; 36(6):717-729. PubMed ID: 36255589
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identification of nine mutant genes and establishment of three prediction models of organ tropism metastases of non-small cell lung cancer.
    Chen S; Huang W; Liu Z; Jin M; Li J; Meng L; Li T; Diao Y; Gao H; Hong C; Zheng J; Li F; Zhang Y; Bi D; Teng L; Li X
    Cancer Med; 2023 Feb; 12(3):3089-3100. PubMed ID: 36161776
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neoadjuvant Immunotherapy Combined with Chemotherapy for Local Advanced Non-small-cell lung cancer in a Patient with a History of Breast cancer: A Case Report.
    Yang RX; Hei Y; Zhu WT; Wang QR; Zhang HM; Chen Y
    Curr Oncol; 2022 Aug; 29(9):6203-6210. PubMed ID: 36135056
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer.
    Liu C; Liu C; Liao J; Yin JC; Wu X; Zhao X; Sun S; Wang H; Hu Z; Zhang Y; Yu H; Shao Y; Wang J
    Lung Cancer; 2022 Sep; 171():18-25. PubMed ID: 35870258
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having her2 alterations.
    Zhuo X; Guo H; Ma J; Lai J; Liu L; Yin K; Zhao J; Wang J; Jiang F; Xu W; Yuan X; Lin X; Fu G
    J Cancer Res Clin Oncol; 2023 May; 149(5):2029-2039. PubMed ID: 35829744
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Portuguese Consensus Recommendations for Next-Generation Sequencing of lung cancer, Rare Tumors, and cancers of Unknown Primary Origin in Clinical Practice.
    R Teixeira M; Oliveira J; Borralho P; O Fernandes MG; Almodovar T; Fernandes I; Macedo D; Ferreira A; Barroso A; Teixeira E; Machado JC
    Acta Med Port; 2022 Sep; 35(9):677-690. PubMed ID: 35816050
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.